Details for Patent: 8,513,249
✉ Email this page to a colleague
Which drugs does patent 8,513,249 protect, and when does it expire?
Patent 8,513,249 protects MIRVASO and is included in one NDA.
This patent has eighty-eight patent family members in twenty-five countries.
Summary for Patent: 8,513,249
Title: | Methods and compositions for safe and effective treatment of erythema |
Abstract: | Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier. |
Inventor(s): | Graeber; Michael (Lawrenceville, NJ), Loesche; Christian (Valbonne, FR), Freidenreich; Philip (Yardley, PA), Liu; Yin-Sang (Princeton, NJ), Leoni; Matthew J. (Hampton, NJ) |
Assignee: | Galderma Laboratories, L.P. (Fort Worth, TX) |
Application Number: | 13/456,976 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,513,249 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 8,513,249
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Galderma Labs Lp | MIRVASO | brimonidine tartrate | GEL;TOPICAL | 204708-001 | Aug 23, 2013 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TOPICAL TREATMENT OF FACIAL ERYTHEMA OF ROSACEA | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,513,249
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | E530185 | ⤷ Try a Trial | |||
Australia | 2004242967 | ⤷ Try a Trial | |||
Australia | 2005247467 | ⤷ Try a Trial | |||
Australia | 2011231543 | ⤷ Try a Trial | |||
Brazil | 112012024289 | ⤷ Try a Trial | |||
Brazil | PI0511519 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |